SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL

Baraliakos X, Gossec L, Pournara E, Jeka S, Blanco R, D'Angelo S, Schett G, Schulz B, Rissler M, Nagar K, Perella C, Coates LC (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 35-36

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

Event location: , ELECTR NETWORK

DOI: 10.1136/annrheumdis-2020-eular.638

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Novartis AG

Switzerland (CH) Ruhr-Universität Bochum (RUB)

Germany (DE) Nicolaus Copernicus University (NCU) / Uniwersytet Mikołaja Kopernika w Toruniu (UMK)

Poland (PL) University of Paris 4 - Paris-Sorbonne / Université paris IV Paris-Sorbonne

France (FR) University of Oxford

United Kingdom (GB) Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV)

Spain (ES) Ospedale San Carlo

Italy (IT)

How to cite

APA:

Baraliakos, X., Gossec, L., Pournara, E., Jeka, S., Blanco, R., D'Angelo, S.,... Coates, L.C. (2020). SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 35-36). , ELECTR NETWORK: LONDON: BMJ PUBLISHING GROUP.

MLA:

Baraliakos, X., et al. "SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL." Proceedings of the Annual European Congress of Rheumatology (EULAR), , ELECTR NETWORK LONDON: BMJ PUBLISHING GROUP, 2020. 35-36.

BibTeX: Download